Dr. Jennifer McVean, MD, stands at the forefront of pediatric endocrinology, dedicating her career to enhancing the lives of children and families affected by diabetes and endocrine disorders. As the Senior Director of Medical Affairs for Medtronic Diabetes, she leverages nearly two decades of clinical practice, research, and medical innovation to drive advancements in diabetes care.
Diagnosed with Type 1 diabetes at the age of 11, Dr. McVean brings a unique perspective to her practice. Her personal journey with the condition fuels her compassionate approach to patient care, allowing her to empathize deeply with the challenges faced by her young patients and their families.
Dr. McVean’s academic journey began at the University of Minnesota Medical School, followed by a pediatric residency at the University of Colorado and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in both Pediatrics and Pediatric Endocrinology.
Throughout her career, Dr. McVean has held esteemed positions at institutions such as the University of Minnesota, Children’s Minnesota, and Gundersen Health System. Her expertise encompasses Type 1 diabetes management, insulin pump therapy, continuous glucose monitoring, growth and thyroid disorders, and the integration of diabetes technology and innovation.
One of her notable contributions includes research on the MiniMed™ 780G system, an advanced hybrid closed-loop insulin delivery system. Studies have demonstrated that this system significantly reduces the burden of diabetes management by improving overnight glycemic control and enhancing sleep quality for patients.
Dr. McVean’s commitment extends beyond clinical practice. She actively participates in organizations such as the Juvenile Diabetes Research Foundation (JDRF), the American Diabetes Association (ADA), and the Pediatric Endocrine Society. Her involvement in these groups underscores her dedication to advocacy, education, and community outreach aimed at improving diabetes awareness and treatment.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.